The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT05820048
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT05820048
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05820048. Randomized; single masking; primary purpose prevention. Start 2023-05-01 (anticipated); primary completion 2024-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
- Acronym
- PPI
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Lansoprazole 15 mg
- Lead sponsor
- Daejeon St. Mary's hospital
- Collaborator
- Jeil Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct05820048- Content hash
efe1db7c47d7aca39e30602f3dd696fc3ddc6d29ec6da585346406e6a79ca4ba